CN118169263A - Cell surface proteome in-situ analysis method based on interaction of host and guest and without calibration - Google Patents
Cell surface proteome in-situ analysis method based on interaction of host and guest and without calibration Download PDFInfo
- Publication number
- CN118169263A CN118169263A CN202211602865.6A CN202211602865A CN118169263A CN 118169263 A CN118169263 A CN 118169263A CN 202211602865 A CN202211602865 A CN 202211602865A CN 118169263 A CN118169263 A CN 118169263A
- Authority
- CN
- China
- Prior art keywords
- protein
- group
- cells
- cell surface
- guest
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 title claims abstract description 82
- 238000000034 method Methods 0.000 title claims abstract description 35
- 108010026552 Proteome Proteins 0.000 title claims abstract description 30
- 238000010249 in-situ analysis Methods 0.000 title claims abstract description 18
- 230000003993 interaction Effects 0.000 title claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 124
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 121
- 239000000523 sample Substances 0.000 claims abstract description 46
- 239000000463 material Substances 0.000 claims abstract description 40
- 108010052285 Membrane Proteins Proteins 0.000 claims abstract description 37
- 102000018697 Membrane Proteins Human genes 0.000 claims abstract description 35
- 238000002372 labelling Methods 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 201000010099 disease Diseases 0.000 claims abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 9
- 238000011065 in-situ storage Methods 0.000 claims abstract description 8
- 239000011159 matrix material Substances 0.000 claims abstract description 7
- 238000000926 separation method Methods 0.000 claims abstract description 7
- 206010059866 Drug resistance Diseases 0.000 claims abstract description 5
- 150000002500 ions Chemical class 0.000 claims abstract description 4
- -1 polycarbonyl Chemical class 0.000 claims description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 14
- 238000005516 engineering process Methods 0.000 claims description 14
- 238000004949 mass spectrometry Methods 0.000 claims description 13
- 239000013592 cell lysate Substances 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 10
- 108090000631 Trypsin Proteins 0.000 claims description 10
- 102000004142 Trypsin Human genes 0.000 claims description 10
- 238000004445 quantitative analysis Methods 0.000 claims description 10
- 239000012588 trypsin Substances 0.000 claims description 10
- 108091005804 Peptidases Proteins 0.000 claims description 9
- 102000007079 Peptide Fragments Human genes 0.000 claims description 9
- 108010033276 Peptide Fragments Proteins 0.000 claims description 9
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 8
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 claims description 8
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 claims description 7
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims description 7
- 239000000377 silicon dioxide Substances 0.000 claims description 7
- 230000014759 maintenance of location Effects 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 150000003384 small molecules Chemical class 0.000 claims description 5
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 4
- 239000006143 cell culture medium Substances 0.000 claims description 4
- 230000024245 cell differentiation Effects 0.000 claims description 4
- 210000000170 cell membrane Anatomy 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 108090000317 Chymotrypsin Proteins 0.000 claims description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims description 2
- 101800000021 N-terminal protease Proteins 0.000 claims description 2
- 102000016387 Pancreatic elastase Human genes 0.000 claims description 2
- 108010067372 Pancreatic elastase Proteins 0.000 claims description 2
- 102000057297 Pepsin A Human genes 0.000 claims description 2
- 108090000284 Pepsin A Proteins 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical group C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical group C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 2
- VTJUKNSKBAOEHE-UHFFFAOYSA-N calixarene Chemical compound COC(=O)COC1=C(CC=2C(=C(CC=3C(=C(C4)C=C(C=3)C(C)(C)C)OCC(=O)OC)C=C(C=2)C(C)(C)C)OCC(=O)OC)C=C(C(C)(C)C)C=C1CC1=C(OCC(=O)OC)C4=CC(C(C)(C)C)=C1 VTJUKNSKBAOEHE-UHFFFAOYSA-N 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 150000001718 carbodiimides Chemical class 0.000 claims description 2
- 239000002041 carbon nanotube Substances 0.000 claims description 2
- 229910021393 carbon nanotube Inorganic materials 0.000 claims description 2
- 229960002376 chymotrypsin Drugs 0.000 claims description 2
- 230000002860 competitive effect Effects 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 2
- 229960000789 guanidine hydrochloride Drugs 0.000 claims description 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 2
- 150000004693 imidazolium salts Chemical class 0.000 claims description 2
- 239000012948 isocyanate Substances 0.000 claims description 2
- 150000002513 isocyanates Chemical class 0.000 claims description 2
- 239000012621 metal-organic framework Substances 0.000 claims description 2
- 239000002105 nanoparticle Substances 0.000 claims description 2
- 229940111202 pepsin Drugs 0.000 claims description 2
- CTRLRINCMYICJO-UHFFFAOYSA-N phenyl azide Chemical group [N-]=[N+]=NC1=CC=CC=C1 CTRLRINCMYICJO-UHFFFAOYSA-N 0.000 claims description 2
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical compound SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 claims description 2
- 230000008261 resistance mechanism Effects 0.000 claims description 2
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical class FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 claims description 2
- GWIKYPMLNBTJHR-UHFFFAOYSA-M thiosulfonate group Chemical group S(=S)(=O)[O-] GWIKYPMLNBTJHR-UHFFFAOYSA-M 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims 3
- 238000012986 modification Methods 0.000 claims 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 238000007385 chemical modification Methods 0.000 claims 2
- 239000000539 dimer Substances 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- GQQSNQUOWKQMKU-UHFFFAOYSA-N 1-butyl-2-chloro-2H-pyridine Chemical compound C(CCC)N1C(C=CC=C1)Cl GQQSNQUOWKQMKU-UHFFFAOYSA-N 0.000 claims 1
- PLWSZOQYWKLNIL-UHFFFAOYSA-N 1-butyl-2-chloro-3-methyl-2h-imidazole Chemical compound CCCCN1C=CN(C)C1Cl PLWSZOQYWKLNIL-UHFFFAOYSA-N 0.000 claims 1
- KAIPKTYOBMEXRR-UHFFFAOYSA-N 1-butyl-3-methyl-2h-imidazole Chemical compound CCCCN1CN(C)C=C1 KAIPKTYOBMEXRR-UHFFFAOYSA-N 0.000 claims 1
- PQTSSOAHDUVSCX-UHFFFAOYSA-N 2-chloro-1-dodecyl-3-methyl-2H-imidazole Chemical compound C(CCCCCCCCCCC)N1C(N(C=C1)C)Cl PQTSSOAHDUVSCX-UHFFFAOYSA-N 0.000 claims 1
- ANJMXIRDWJMCLJ-UHFFFAOYSA-N 2-chloro-1-ethyl-3-methyl-2h-imidazole Chemical compound CCN1C=CN(C)C1Cl ANJMXIRDWJMCLJ-UHFFFAOYSA-N 0.000 claims 1
- DNYZOGZGNPPKQA-UHFFFAOYSA-N 2-chloro-1-methyl-3-octyl-2h-imidazole Chemical compound CCCCCCCCN1C=CN(C)C1Cl DNYZOGZGNPPKQA-UHFFFAOYSA-N 0.000 claims 1
- PXKPKGHXANCVMC-UHFFFAOYSA-N 3-butyl-1-methyl-1,2-dihydroimidazol-1-ium;trifluoromethanesulfonate Chemical compound OS(=O)(=O)C(F)(F)F.CCCCN1CN(C)C=C1 PXKPKGHXANCVMC-UHFFFAOYSA-N 0.000 claims 1
- 238000007259 addition reaction Methods 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 1
- 230000001588 bifunctional effect Effects 0.000 claims 1
- 150000001638 boron Chemical class 0.000 claims 1
- 229910002091 carbon monoxide Inorganic materials 0.000 claims 1
- 238000000975 co-precipitation Methods 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- MSBXTPRURXJCPF-DQWIULQBSA-N cucurbit[6]uril Chemical compound N1([C@@H]2[C@@H]3N(C1=O)CN1[C@@H]4[C@@H]5N(C1=O)CN1[C@@H]6[C@@H]7N(C1=O)CN1[C@@H]8[C@@H]9N(C1=O)CN([C@H]1N(C%10=O)CN9C(=O)N8CN7C(=O)N6CN5C(=O)N4CN3C(=O)N2C2)C3=O)CN4C(=O)N5[C@@H]6[C@H]4N2C(=O)N6CN%10[C@H]1N3C5 MSBXTPRURXJCPF-DQWIULQBSA-N 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 claims 1
- 125000003700 epoxy group Chemical group 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 125000005179 haloacetyl group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 150000002463 imidates Chemical class 0.000 claims 1
- 210000002865 immune cell Anatomy 0.000 claims 1
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 claims 1
- 238000001819 mass spectrum Methods 0.000 claims 1
- 238000005464 sample preparation method Methods 0.000 claims 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical group O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims 1
- 239000013595 supernatant sample Substances 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
- 238000009509 drug development Methods 0.000 abstract description 3
- 230000003915 cell function Effects 0.000 abstract description 2
- 238000004891 communication Methods 0.000 abstract description 2
- 230000004069 differentiation Effects 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000008054 signal transmission Effects 0.000 abstract description 2
- 238000004811 liquid chromatography Methods 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- 239000006228 supernatant Substances 0.000 description 24
- 108090000765 processed proteins & peptides Proteins 0.000 description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 238000005119 centrifugation Methods 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 12
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 9
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 9
- 239000001099 ammonium carbonate Substances 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 8
- 239000007791 liquid phase Substances 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 8
- 102000035195 Peptidases Human genes 0.000 description 7
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 6
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 6
- 235000019419 proteases Nutrition 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000012043 crude product Substances 0.000 description 5
- 239000012139 lysis buffer Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000002525 ultrasonication Methods 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- 241000372033 Andromeda Species 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229910052796 boron Inorganic materials 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000006862 enzymatic digestion Effects 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 238000003368 label free method Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000000171 quenching effect Effects 0.000 description 4
- 238000002390 rotary evaporation Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000031018 biological processes and functions Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000008004 cell lysis buffer Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000035992 intercellular communication Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000003983 crown ethers Chemical class 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- GPRSOIDYHMXAGW-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopentanecarboxylic acid iron Chemical compound [CH-]1[CH-][CH-][C-]([CH-]1)C(=O)O.[CH-]1C=CC=C1.[Fe] GPRSOIDYHMXAGW-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical compound O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- IPHBBZWQWUFXGR-UHFFFAOYSA-N 1-butyl-2H-pyridine hydrochloride Chemical compound CCCCN1CC=CC=C1.Cl IPHBBZWQWUFXGR-UHFFFAOYSA-N 0.000 description 1
- IAZSXUOKBPGUMV-UHFFFAOYSA-N 1-butyl-3-methyl-1,2-dihydroimidazol-1-ium;chloride Chemical compound [Cl-].CCCC[NH+]1CN(C)C=C1 IAZSXUOKBPGUMV-UHFFFAOYSA-N 0.000 description 1
- FRZPYEHDSAQGAS-UHFFFAOYSA-M 1-butyl-3-methylimidazol-3-ium;trifluoromethanesulfonate Chemical compound [O-]S(=O)(=O)C(F)(F)F.CCCC[N+]=1C=CN(C)C=1 FRZPYEHDSAQGAS-UHFFFAOYSA-M 0.000 description 1
- IQQRAVYLUAZUGX-UHFFFAOYSA-N 1-butyl-3-methylimidazolium Chemical compound CCCCN1C=C[N+](C)=C1 IQQRAVYLUAZUGX-UHFFFAOYSA-N 0.000 description 1
- WREWAMXVXPPKQU-UHFFFAOYSA-N 1-dodecyl-3-methyl-1,2-dihydroimidazol-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[NH+]1CN(C)C=C1 WREWAMXVXPPKQU-UHFFFAOYSA-N 0.000 description 1
- FQERWQCDIIMLHB-UHFFFAOYSA-N 1-ethyl-3-methyl-1,2-dihydroimidazol-1-ium;chloride Chemical compound [Cl-].CC[NH+]1CN(C)C=C1 FQERWQCDIIMLHB-UHFFFAOYSA-N 0.000 description 1
- WXJHMNWFWIJJMN-UHFFFAOYSA-N 1-methyl-3-octyl-1,2-dihydroimidazol-1-ium;chloride Chemical compound [Cl-].CCCCCCCCN1C[NH+](C)C=C1 WXJHMNWFWIJJMN-UHFFFAOYSA-N 0.000 description 1
- PBIDWHVVZCGMAR-UHFFFAOYSA-N 1-methyl-3-prop-2-enyl-2h-imidazole Chemical compound CN1CN(CC=C)C=C1 PBIDWHVVZCGMAR-UHFFFAOYSA-N 0.000 description 1
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000009127 Glutaminase Human genes 0.000 description 1
- 108010073324 Glutaminase Proteins 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 108091006004 biotinylated proteins Proteins 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- ZICQBHNGXDOVJF-UHFFFAOYSA-N diamantane Chemical compound C1C2C3CC(C4)CC2C2C4C3CC1C2 ZICQBHNGXDOVJF-UHFFFAOYSA-N 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 108091007999 druggable proteins Proteins 0.000 description 1
- 102000038037 druggable proteins Human genes 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000010201 enrichment analysis Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 150000004676 glycans Chemical group 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000001466 metabolic labeling Methods 0.000 description 1
- 230000004879 molecular function Effects 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 229940054441 o-phthalaldehyde Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000003068 pathway analysis Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001282 polysaccharide Chemical group 0.000 description 1
- 239000005017 polysaccharide Chemical group 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- PWEBUXCTKOWPCW-UHFFFAOYSA-L squarate Chemical compound [O-]C1=C([O-])C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-L 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8624—Detection of slopes or peaks; baseline correction
- G01N30/8631—Peaks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及一种新型的细胞表面蛋白质组原位分析方法,属于生物分析技术领域。The invention relates to a novel in-situ analysis method of cell surface proteome, belonging to the technical field of biological analysis.
背景技术Background technique
细胞表面蛋白质是指暴露在细胞表面的蛋白,包括并充当活细胞的第一屏障,并负责执行许多关键功能,包括细胞间相互作用、信号转导和分子运输等。细胞表面蛋白表达的差异不但是区分不同类型细胞的重要标志物更是正常细胞和患病细胞间表型和功能差异的基础,因此近2/3的药物靶蛋白都属于细胞表面蛋白。鉴定细胞表面蛋白质组并研究这些蛋白的性质是理解基本生物学过程和寻找药物开发中新作用靶点的关键步骤(ExpertReview of Proteomics,2010,7(1),141-154;J.Sep.Sci.,2020,43,292–312)。Cell surface proteins refer to proteins exposed on the cell surface, including and acting as the first barrier of living cells, and are responsible for performing many key functions, including cell-to-cell interactions, signal transduction, and molecular transport. Differences in the expression of cell surface proteins are not only important markers for distinguishing different types of cells, but also the basis for phenotypic and functional differences between normal cells and diseased cells. Therefore, nearly 2/3 of drug target proteins are cell surface proteins. Identifying the cell surface proteome and studying the properties of these proteins are key steps in understanding basic biological processes and finding new targets for drug development (Expert Review of Proteomics, 2010, 7(1), 141-154; J. Sep. Sci., 2020, 43, 292–312).
由于低丰度、高疏水性和高异质性的特点限制了细胞表面蛋白的分离和提取效率,因此获得细胞表面蛋白质组的全局谱图一直是蛋白质组学的一大挑战。近些年化学蛋白质组学的兴起,为细胞表面蛋白的鉴定提供了新的工具,即通过化学标记表面暴露的蛋白质或糖链的侧链基团(例如伯胺、羧基、聚糖侧链),随后利用亲和纯化将标记的表面蛋白分离,如糖捕获、代谢标记和细胞表面生物化等方法。这类技术的主要优点是,化学标记试剂可以根据目标生物结构或需求进行定制化设计,仅需要较少的起始细胞量即可获得高纯度的细胞表面蛋白。目前最常使用的是细胞表面生物素化,即在细胞表面蛋白上修饰小分子生物素,并使用受体链霉亲和素特异性提取标记蛋白,但生物素-亲和素体系会存在污染富集的蛋白样品的风险,一是源于细胞存在的内源性生物素化蛋白的干扰,掩盖低丰度蛋白,降低检测灵敏度;二是链霉亲和素本身也是蛋白也会被酶解,可能成为样品中的高丰度污染蛋白;此外,在高温或苛刻的洗涤条件下链霉亲和素也易会变性从而脱离基质材料,导致富集蛋白的丢失,阻碍低丰度细胞表面蛋白的鉴定(Nature Chemistry,2011,3,154-159)。因此本专利使用化学合成的、尺寸更小、物化稳定性更高的主客体相互作用体系进行细胞表面蛋白的分析,获得稳定重现的、纯度更高、覆盖度更深的表面蛋白质组信息。Since the low abundance, high hydrophobicity and high heterogeneity limit the separation and extraction efficiency of cell surface proteins, obtaining a global spectrum of the cell surface proteome has always been a major challenge in proteomics. The rise of chemical proteomics in recent years has provided new tools for the identification of cell surface proteins, namely, chemically labeling the side chain groups of surface-exposed proteins or sugar chains (such as primary amines, carboxyl groups, and polysaccharide side chains), and then using affinity purification to separate the labeled surface proteins, such as sugar capture, metabolic labeling, and cell surface biochemical methods. The main advantage of this type of technology is that chemical labeling reagents can be customized according to the target biological structure or needs, and only a small amount of starting cells is required to obtain high-purity cell surface proteins. At present, the most commonly used method is cell surface biotinylation, that is, modifying small molecule biotin on cell surface proteins and using receptor streptavidin to specifically extract labeled proteins. However, the biotin-avidin system has the risk of contaminating the enriched protein sample. First, the interference of endogenous biotinylated proteins in cells masks low-abundance proteins and reduces the detection sensitivity; second, streptavidin itself is also a protein and will be enzymatically hydrolyzed, which may become a high-abundance contaminating protein in the sample; in addition, under high temperature or harsh washing conditions, streptavidin is also easy to denature and detach from the matrix material, resulting in the loss of enriched proteins and hindering the identification of low-abundance cell surface proteins (Nature Chemistry, 2011, 3, 154-159). Therefore, this patent uses a chemically synthesized, smaller-sized, and more physicochemically stable host-guest interaction system to analyze cell surface proteins, and obtain stable and reproducible surface proteome information with higher purity and deeper coverage.
主客体相互作用是指主体与客体分子通过非共价键相互作用而形成包合物的一类超分子化学。目前发展的主体分子主要包括冠醚、环糊精、葫芦脲、柱芳烃和杯芳烃几类,它们主要通过疏水相互作用、氢键、静电相互作用、π-π堆叠等非共价相互作用特异性识别并高亲和力结合如金刚烷、二茂铁、碳硼烷及其衍生物以及富含阳离子或阴离子的客体分子,并且这种结合是可逆的。基于上述特点,主客体相互作用已被应用于多个领域,如生物传感器、催化调控、水下粘合剂的开发、蛋白分离、药物递送等。Host-guest interaction refers to a type of supramolecular chemistry in which the host and guest molecules form inclusion complexes through non-covalent interactions. The host molecules currently under development mainly include crown ethers, cyclodextrins, cucurbiturils, pillar aromatics and calix aromatics. They specifically recognize and bind with high affinity to guest molecules such as adamantane, ferrocene, carborane and its derivatives, as well as cation- or anion-rich molecules through non-covalent interactions such as hydrophobic interactions, hydrogen bonds, electrostatic interactions, and π-π stacking, and this binding is reversible. Based on the above characteristics, host-guest interactions have been applied to many fields, such as biosensors, catalytic regulation, development of underwater adhesives, protein separation, drug delivery, etc.
在细胞表面蛋白分离上,主客体识别技术由于具有稳定的化学结构,因此不易受酶解或苛刻洗涤条件的影响导致捕获蛋白的丢失,而且可以通过施加竞争客体分子来选择性释放捕获的蛋白,便于进行质谱鉴定。此外,由于化学合成的可扩展性,在低廉易得的同时,主客体识别分子还可根据分析目的的不同进行改造,提高方法的专一性和灵敏度。通过与蛋白免疫印迹、荧光成像等分析技术的结合,证明了其相对于常用的生物素-亲和素体系具有更高的富集效率、更低的非特异性吸附蛋白干扰,并且可以在温和条件下释放富集的蛋白,还可以实现蛋白质的精准成像(Nature Chemistry,2011,3,154-159;NatureCommunications,2018,9,1712-1722)。但该技术尚未与基于质谱的蛋白质组定量分析相结合对细胞表面蛋白质组进行全局的分析。In the separation of cell surface proteins, the host-guest recognition technology has a stable chemical structure, so it is not easily affected by enzymatic hydrolysis or harsh washing conditions, resulting in the loss of captured proteins, and can selectively release captured proteins by applying competitive guest molecules, which is convenient for mass spectrometry identification. In addition, due to the scalability of chemical synthesis, while being cheap and easy to obtain, the host-guest recognition molecules can also be transformed according to the different analysis purposes to improve the specificity and sensitivity of the method. Through the combination with analytical techniques such as protein immunoblotting and fluorescence imaging, it has been proved that it has higher enrichment efficiency and lower non-specific adsorption protein interference than the commonly used biotin-avidin system, and can release enriched proteins under mild conditions, and can also achieve accurate imaging of proteins (Nature Chemistry, 2011, 3, 154-159; Nature Communications, 2018, 9, 1712-1722). However, this technology has not yet been combined with mass spectrometry-based proteome quantitative analysis to analyze the cell surface proteome globally.
无标定量技术是通过液质联用技术对蛋白质酶解肽段进行质谱分析,无需使用昂贵的稳定同位素标签做内标,只需比较不同样品中相应肽段的信号强度,从而对肽段对应的蛋白质进行相对定量。无标定量可以同时对多组样品进行定量分析提高了实验的通量。The label-free quantitative technology uses liquid chromatography-mass spectrometry to analyze protein enzymatic peptides. It does not require the use of expensive stable isotope labels as internal standards. It only needs to compare the signal intensity of the corresponding peptides in different samples to perform relative quantification of the proteins corresponding to the peptides. Label-free quantitative analysis can simultaneously perform quantitative analysis on multiple groups of samples, which improves the throughput of the experiment.
因此为了深度精准解析细胞表面蛋白质组,将具有高亲和力和动态结合的主客体识别技术与基于质谱的蛋白质组无标定量分析相结合,能够。Therefore, in order to deeply and accurately analyze the cell surface proteome, it is possible to combine the host-guest recognition technology with high affinity and dynamic binding with mass spectrometry-based proteome label-free quantitative analysis.
在本专利中,针对现有生物素-亲和素标记体系可能污染富集蛋白、易丢失低丰度蛋白、难以回收富集蛋白等问题,利用具备高结合亲和力、物化稳定性好、生物背景低和标记蛋白的温和释放等特点的主客体识别技术,并将其与质谱定量分析方法相结合,发展出基于主客体相互作用和无标定量的细胞表面蛋白质组原位分析方法,以实现对细胞表面蛋白质的深度精准解析。In this patent, in order to address the problems of the existing biotin-avidin labeling system, such as possible contamination of enriched proteins, easy loss of low-abundance proteins, and difficulty in recovering enriched proteins, a host-guest recognition technology with the characteristics of high binding affinity, good physicochemical stability, low biological background and gentle release of labeled proteins is utilized, and it is combined with a mass spectrometry quantitative analysis method to develop an in situ analysis method of the cell surface proteome based on host-guest interaction and label-free quantification, so as to achieve in-depth and accurate analysis of cell surface proteins.
发明内容Summary of the invention
本发明的目的是提供一种基于主客体相互作用和无标定量的细胞表面蛋白质组原位分析方法,通过本发明的方法实现了在细胞原位环境下细胞表面蛋白质组的全局分析。The purpose of the present invention is to provide a method for in situ analysis of cell surface proteome based on host-guest interaction and label-free quantification. The method of the present invention realizes global analysis of cell surface proteome in an in situ cell environment.
一种基于主客体相互作用和无标定量的细胞表面蛋白质组原位分析方法,具体包括以下步骤:A method for in situ analysis of cell surface proteome based on host-guest interaction and label-free quantification, specifically comprising the following steps:
(1)制备主体富集材料,将主体基团共价键合在基质材料上,主体基团由冠醚、葫芦[n]脲(n=5-8,10,14)、环糊精、杯芳烃、柱[n]芳烃(n=5、6)中的一种或两种以上组成;基质材料主要为琼脂糖、高分子聚合物纳米颗粒、介孔二氧化硅材料、碳纳米管、四氧化三铁磁球、金属有机框架材料等中的一种或两种以上。(1) Preparing a host-enriched material, covalently bonding the host group to a matrix material, wherein the host group is composed of one or more of crown ethers, cucurbit[n]urils (n=5-8, 10, 14), cyclodextrins, calixarene, and pillar[n]arene (n=5, 6); the matrix material is mainly one or more of agarose, polymer nanoparticles, mesoporous silica materials, carbon nanotubes, ferroferric oxide magnetic spheres, metal organic framework materials, etc.
从提高与客体分子结合亲和力、降低非特异性吸附和对蛋白样品潜在的污染两个方面构建主体富集材料,从表面亲水性、材料的物化稳定性(如耐酸碱、去垢剂、高温等)方面加以优化获得非特异性吸附低、对样品污染小的基质材料;通过调整主体基团的键合量、主体基团种类从而提升富集效率。The main enrichment material is constructed from two aspects: improving the binding affinity with the guest molecules and reducing nonspecific adsorption and potential contamination of protein samples. The surface hydrophilicity and the physicochemical stability of the material (such as resistance to acids and alkalis, detergents, high temperatures, etc.) are optimized to obtain a matrix material with low nonspecific adsorption and little sample contamination. The enrichment efficiency is improved by adjusting the bonding amount and type of the main group.
(2)制备客体标记探针,将客体基团与标记基团连接;客体基团可为:二茂铁、金刚烷、二聚金刚烷、多面体硼簇、铵盐、咪唑鎓盐和吡啶鎓盐及它们的衍生物中的一种或两种以上;标记基团包括:磺基琥珀酰亚胺酯、N-琥珀酰亚胺酯、酰基间苯三酚、邻苯二甲醛、方酸盐、磺酰氟、聚羰基、醛酮、卤代芳烃或亚胺酸酯、马来酰亚胺、2-巯基吡啶、硫代磺酸盐、卤代乙酰基或吡啶基二硫化物、碳化二亚胺或异氰酸盐、酰肼、苯酚基团、二苯甲酮基团、苯基叠氮基团、三氟甲基双吖丙啶、双吖丙啶或2-芳基-5-羧基四唑等中的一种或两种以上。(2) preparing a guest labeled probe and connecting the guest group to the labeling group; the guest group may be one or more of ferrocene, adamantane, diamantane, polyhedral boron cluster, ammonium salt, imidazolium salt and pyridinium salt and their derivatives; the labeling group includes one or more of sulfosuccinimide ester, N-succinimide ester, acyl pyrrolidone, o-phthalaldehyde, squarate, sulfonyl fluoride, polycarbonyl, aldehyde ketone, halogenated aromatic hydrocarbon or imide ester, maleimide, 2-thiopyridine, thiosulfonate, halogenated acetyl or pyridyl disulfide, carbodiimide or isocyanate, hydrazide, phenol group, benzophenone group, phenylazide group, trifluoromethylbis(aziridine), bis(aziridine) or 2-aryl-5-carboxytetrazole, etc.
基于良好的不透膜性、生物相容快速高效的反应性、反应位点互补性以及与主体分子以高结合性的原则设计客体标记探针,通过在标记基团上引入带负电的基团、使用亲水性强的连接臂来使探针难以透膜,主要与细胞表面蛋白进行反应;选择反应位点不同且具有较好选择性的标记基团或位点非特异性的光交联标记基团、引入可以与蛋白氨基酸侧链发生非共价作用的基团来实现生物相容性好、反应效率高、位点互补的要求;从客体基团种类、带电性不同的侧链基团方面加以优化获得可被主体富集材料高效特异性识别的客体标记探针。The guest-labeled probe is designed based on the principles of good membrane impermeability, biocompatibility, rapid and efficient reactivity, reaction site complementarity and high binding with the main molecule. By introducing negatively charged groups on the labeling group and using highly hydrophilic connecting arms, the probe is made difficult to penetrate the membrane and mainly reacts with cell surface proteins; labeling groups with different reaction sites and good selectivity or site-nonspecific photocross-linking labeling groups are selected, and groups that can non-covalently interact with the amino acid side chains of proteins are introduced to achieve the requirements of good biocompatibility, high reaction efficiency and site complementarity; optimization is carried out in terms of the type of guest groups and side chain groups with different charges to obtain guest-labeled probes that can be efficiently and specifically recognized by the main enrichment material.
(3)客体标记探针标记细胞表面蛋白。将客体标记探针与细胞在无血清培养基中,4℃或37℃,5% CO2条件下,共同孵育5分钟-12小时,收集细胞。由于探针透膜性差,因此主要聚集在细胞膜外侧或细胞间,随后标记基团通过与亲核氨基酸的侧链发生共价反应或在紫外光驱动下生成自由基插入蛋白上的X-H(X=C,N,O)键中,从而将客体基团修饰到细胞表面蛋白上。(3) Labeling cell surface proteins with guest-labeled probes. Incubate the guest-labeled probes and cells in serum-free medium at 4°C or 37°C and 5% CO2 for 5 minutes to 12 hours, and collect the cells. Since the probes have poor membrane permeability, they mainly accumulate on the outside of the cell membrane or between cells. The labeling group then undergoes a covalent reaction with the side chain of the nucleophilic amino acid or generates free radicals driven by ultraviolet light to insert into the XH (X=C, N, O) bond on the protein, thereby modifying the guest group onto the cell surface protein.
(4)破碎细胞,于收集到的细胞中加入含0.5-5%(v/v)蛋白酶抑制剂cocktail的细胞裂解液,每3×106个细胞加入200-600μL裂解液,超声破碎细胞,10000-16000g离心5-30分钟,取出上清液,获得蛋白质混合样品。(4) Disrupt the cells. Add cell lysis buffer containing 0.5-5% (v/v) protease inhibitor cocktail to the collected cells. Add 200-600 μL of lysis buffer for every 3×10 6 cells. Disrupt the cells by ultrasonication. Centrifuge at 10,000-16,000 g for 5-30 minutes. Remove the supernatant to obtain a protein mixed sample.
所述细胞裂解液包括:1-丁基-3-甲基咪唑四氟硼酸盐、1-丁基-3-甲基咪唑四氟醋酸盐、1-丁基-3-甲基咪唑三氟甲磺酸盐、溴化-1-丁基-3-甲基-咪唑四氟硼酸盐、氯化-1-丁基-3-甲基-咪唑、氯化-1-乙基-3-甲基咪唑、氯化-1-辛基-3-甲基咪唑、氯化-1-十二烷基-3-甲基咪唑、氯化-1-烯丙基-3-甲基咪唑、1-氨丙基-3-甲基咪唑四氟硼酸盐、1-羟乙基-3-甲基咪唑四氟硼酸盐、氯化-N-丁基吡啶、N-丁基吡啶四氟硼酸盐、尿素、盐酸胍、十二烷基硫酸钠;The cell lysate comprises: 1-butyl-3-methylimidazolium tetrafluoroborate, 1-butyl-3-methylimidazolium tetrafluoroacetate, 1-butyl-3-methylimidazolium trifluoromethanesulfonate, 1-butyl-3-methyl-imidazolium bromide tetrafluoroborate, 1-butyl-3-methyl-imidazole chloride, 1-ethyl-3-methylimidazole chloride, 1-octyl-3-methylimidazole chloride, 1-dodecyl-3-methylimidazole chloride, 1-allyl-3-methylimidazole chloride, 1-aminopropyl-3-methylimidazole tetrafluoroborate, 1-hydroxyethyl-3-methylimidazole tetrafluoroborate, N-butylpyridine chloride, N-butylpyridine tetrafluoroborate, urea, guanidine hydrochloride, and sodium dodecyl sulfate;
细胞与细胞裂解液的比例为:3×106个细胞加入200-600μl细胞裂解液;The ratio of cells to cell lysis buffer was: 3 × 10 6 cells added to 200-600 μl of cell lysis buffer;
细胞裂解液中蛋白酶抑制剂cocktail占比为0.5-5%(v/v);The proportion of protease inhibitor cocktail in cell lysate is 0.5-5% (v/v);
超声功率为80-160W,超声时间为1-5分钟。The ultrasonic power is 80-160W, and the ultrasonic time is 1-5 minutes.
(5)富集细胞表面蛋白。将得到的蛋白混合样品与主体富集材料,以1mg全蛋白加入0.1-10mg的富集材料的比例混合,在4-37℃下,共孵育2-16小时。使主体富集材料与蛋白上的客体分子充分接触并实现高结合亲和力的结合,从而将修饰有客体分子的细胞表面蛋白富集在材料上;1000-16000g离心5-10分钟,弃去上清,将细胞表面蛋白与其他胞内蛋白分离开来。(5) Enrichment of cell surface proteins. The obtained protein mixed sample is mixed with the main enrichment material at a ratio of 1 mg of whole protein to 0.1-10 mg of enrichment material, and incubated at 4-37°C for 2-16 hours. The main enrichment material is fully in contact with the guest molecule on the protein and achieves high binding affinity, so that the cell surface protein modified with the guest molecule is enriched on the material; centrifuge at 1000-16000g for 5-10 minutes, discard the supernatant, and separate the cell surface protein from other intracellular proteins.
(6)对富集到的蛋白质进行处理(6) Processing of the enriched proteins
采用直接在富集材料上对富集的蛋白进行酶解处理:将富集有蛋白的材料分散在细胞裂解中,加入二硫苏糖醇或三(2-羧乙基)膦,25-37℃变性还原5分钟-2小时,1000-16000g离心5-10分钟,弃去上清;重新用细胞裂解液分散蛋白变性后的富集材料,利用碘乙酰胺进行25℃下避光烷基化20-40分钟,离心并弃去上清;用50mM碳酸氢铵充分分散蛋白烷基化后的富集材料,加入蛋白酶,以1:20-1:50(w/w)的蛋白酶与蛋白质复合物的比例进行12-16小时酶解,1000-16000g离心5-10min,收集含有肽段样品的上清;The enriched protein is directly enzymatically treated on the enriched material: the protein-enriched material is dispersed in the cell lysate, dithiothreitol or tris(2-carboxyethyl)phosphine is added, the material is denatured and reduced at 25-37°C for 5 minutes to 2 hours, centrifuged at 1000-16000g for 5-10 minutes, and the supernatant is discarded; the enriched material after protein denaturation is dispersed again with the cell lysate, alkylated with iodoacetamide at 25°C for 20-40 minutes in the dark, centrifuged and the supernatant is discarded; the enriched material after protein alkylation is fully dispersed with 50mM ammonium bicarbonate, protease is added, enzymatic hydrolysis is performed at a ratio of protease to protein complex of 1:20-1:50 (w/w) for 12-16 hours, centrifuged at 1000-16000g for 5-10 minutes, and the supernatant containing the peptide sample is collected;
或者,竞争洗脱富集材料上的蛋白并用FASP进行样品预处理。将富集有蛋白的材料分散在细胞裂解液中,加入与主体基团结合亲和力更强的客体小分子(1,1'-双(三甲基氨甲基)二茂铁、)在25-95℃下共孵育5分钟-2小时,离心收集含有蛋白的上清;向洗脱的蛋白溶液中加入二硫苏糖醇或三(2-羧乙基)膦,高温变性还原,所述高温变性的温度为37-95℃,时间为5分钟-2小时;将样品转移至3k-10k Da滤膜上,利用碘乙酰胺进行避光烷基化20-40分钟;加入蛋白酶,1:2000-1:5000(w/w)的蛋白酶:总蛋白比例的比例进行12-16小时酶解,离心收集肽段样品。Alternatively, competitively elute the protein on the enriched material and pre-treat the sample with FASP. Disperse the protein-enriched material in the cell lysate, add a small guest molecule (1,1'-bis(trimethylaminomethyl)ferrocene) with stronger binding affinity to the main group, incubate at 25-95°C for 5 minutes to 2 hours, and collect the supernatant containing the protein by centrifugation; add dithiothreitol or tris(2-carboxyethyl)phosphine to the eluted protein solution, denature and reduce at high temperature, the temperature of the high temperature denaturation is 37-95°C, and the time is 5 minutes to 2 hours; transfer the sample to a 3k-10k Da filter membrane, and use iodoacetamide to alkylate in the dark for 20-40 minutes; add protease, and enzymatically hydrolyze for 12-16 hours at a ratio of protease: total protein of 1:2000-1:5000 (w/w), and collect the peptide sample by centrifugation.
其中,所用蛋白酶包括胰蛋白酶、赖氨酰胺内切酶、胰凝乳蛋白酶、赖氨酸精氨酸N端蛋白酶、胃蛋白酶、弹性蛋白酶、谷氨酰胺内切酶、天冬氨酰蛋白内切酶、LysN蛋白酶、ArgC蛋白酶中的一种或二种以上;The proteases used include one or more of trypsin, lysinamidase, chymotrypsin, lysine arginine N-terminal protease, pepsin, elastase, glutaminase, aspartyl proteinase, LysN protease, and ArgC protease;
所述的与主体基团结合亲和力更强的客体小分子包括:主要为1,1'-双(三甲基氨甲基)二茂铁、二聚金刚烷二铵离子等中的一种或二种以上。The guest small molecules with stronger binding affinity with the main group include: mainly one or more of 1,1'-bis(trimethylaminomethyl)ferrocene, dimeric adamantane diammonium ion and the like.
(7)对收集到的肽段样品采用液质联用无标定量分析技术进行分析,利用C18色谱柱进行样品分离,利用高分辨质谱进行数据采集。所述的无标定量分析技术是基于离子流色谱峰的蛋白定量算法,无需向蛋白样品中引入额外的定量标签,仅保持样品起始蛋白量一致即可,肽段样品经质谱采集后,将一级谱图的质谱数据转化成以色谱保留时间(Retention time)、质荷比(m/z)、一级谱图中肽段的强度(Intensity)为变量的三维图谱,即提取相应质荷比在不同保留时间点上的所有同位素峰信号强度,利用MaxquantLFQ(MaxLFQ)算法模块解析这些肽段的定量信息,从而获得对应蛋白质的相对定量比值。(7) The collected peptide samples were analyzed by liquid chromatography-mass spectrometry (LC-MS) standard-free quantitative analysis technology, sample separation was performed using a C18 chromatographic column, and data was collected using a high-resolution mass spectrometer. The standard-free quantitative analysis technology is a protein quantitative algorithm based on ion current chromatographic peaks. No additional quantitative labels need to be introduced into the protein sample. Only the initial protein amount of the sample needs to be kept consistent. After the peptide samples are collected by mass spectrometry, the mass spectrometry data of the primary spectrum is converted into a three-dimensional map with chromatographic retention time (Retention time), mass-to-charge ratio (m/z), and intensity of the peptide in the primary spectrum as variables, that is, all isotope peak signal intensities of the corresponding mass-to-charge ratio at different retention time points are extracted, and the quantitative information of these peptides is analyzed using the MaxquantLFQ (MaxLFQ) algorithm module to obtain the relative quantitative ratio of the corresponding protein.
通过蛋白的LFQ强度差异初步鉴定与疾病、细胞分化、耐药机制等表型相关的细胞表面蛋白标志物(组间样品的LFQ强度差异大于1.5的蛋白);Cell surface protein markers related to diseases, cell differentiation, drug resistance mechanisms and other phenotypes were preliminarily identified through differences in LFQ intensity of proteins (proteins with LFQ intensity differences greater than 1.5 between group samples);
同时,使用二级谱图对鉴定到的蛋白的肽段进行序列测定从而进行蛋白鉴定。At the same time, the peptide fragments of the identified protein are sequenced using the secondary spectrum to perform protein identification.
(8)利用软件Proteome Discoverer(Thermo Fisher)、Maxquant(https://www.maxquant.org/)对质谱数据进行解析,对富集的蛋白进行定性分析,并使用Maxquant中的Label-free quantification模块进行定量分析,比较在不同培养、刺激条件下或不同种类细胞之间细胞表面蛋白的表达差异,初步获得与疾病、细胞分化、细胞间通讯等相关的潜在表面蛋白。(8) The mass spectrometry data were analyzed using the software Proteome Discoverer (Thermo Fisher) and Maxquant (https://www.maxquant.org/), and the enriched proteins were qualitatively analyzed. The label-free quantification module in Maxquant was used for quantitative analysis to compare the expression differences of cell surface proteins under different culture and stimulation conditions or between different types of cells, and to preliminarily obtain potential surface proteins related to diseases, cell differentiation, and intercellular communication.
(9)使用Uniprot(https://www.uniprot.org/)、DAVID BioinformaticsResources(https://david.ncifcrf.gov/)、GORILLA(http://cbl-gorilla.cs.technion.ac.il/)、PANTHER Classification System(http://pantherdb.org/)、KEGG(https://www.genome.jp/kegg/)等搜索引擎对鉴定到的蛋白进行基因本体注释和富集分析(GO分析)和KEGG通路分析,收集p值小于等于0.05或FDR小于等于1%的分子功能、生物过程、细胞组成和KEGG通路的注释信息,分析鉴定到的蛋白具体的定位及功能信息并获得其所参与的生物学过程以及蛋白通路信息。(9) Use search engines such as Uniprot (https://www.uniprot.org/), DAVID Bioinformatics Resources (https://david.ncifcrf.gov/), GORILLA (http://cbl-gorilla.cs.technion.ac.il/), PANTHER Classification System (http://pantherdb.org/), and KEGG (https://www.genome.jp/kegg/) to perform gene ontology annotation and enrichment analysis (GO analysis) and KEGG pathway analysis on the identified proteins. Collect annotation information on molecular functions, biological processes, cellular composition, and KEGG pathways with p values less than or equal to 0.05 or FDR less than or equal to 1%. Analyze the specific localization and functional information of the identified proteins and obtain information on the biological processes and protein pathways in which they participate.
进一步通过获得的信息,确定可作为潜在疾病标志物,可作为药物靶点,或对于细胞分化、分子运输、胞间通讯具有重要意义的细胞表面蛋白。The information obtained can be used to further identify cell surface proteins that can serve as potential disease markers, drug targets, or are important for cell differentiation, molecular transport, and intercellular communication.
本发明利用主客体相互作用的高结合亲和力、特异性识别以及温和条件下可控释放的特点,将其引入细胞表面蛋白的全局原位分析中。利用多种具有不同反应位点的客体标记探针分别在原位环境下标记细胞表面蛋白质,将细胞裂解,将固载主体分子的富集材料投入细胞裂解物中,利用主客体的高结合亲和力和特异性相互作用对被客体分子标记的细胞表面蛋白进行富集分离,富集后的蛋白可根据下游需要进行材料上酶解或通过施加与主体基团结合亲和力更强的客体小分子将富集的蛋白竞争洗脱并利用FASP进行样品预处理,结合液质联用技术和无标定量方法,对细胞表面蛋白质组进行原位分析。这一方法对于解析细胞间通讯、离子和其他分子的运输以及信号级联的传递,理解疾病、免疫、耐药以及细胞功能分化等涉及的通路,寻找新的疾病标志物以及药物开发中的新作用靶点具有重要意义,进而对疾病的发生发展、药物治疗、抑制耐药现象提供理论支撑。The present invention utilizes the characteristics of high binding affinity, specific recognition and controlled release under mild conditions of host-guest interaction, and introduces it into the global in situ analysis of cell surface proteins. A variety of guest-labeled probes with different reaction sites are used to label cell surface proteins in an in situ environment, the cells are lysed, and the enriched material of the immobilized host molecule is put into the cell lysate. The high binding affinity and specific interaction of the host and guest are used to enrich and separate the cell surface proteins labeled by the guest molecule. The enriched protein can be enzymatically hydrolyzed on the material according to the downstream needs, or the enriched protein can be competitively eluted by applying a guest small molecule with a stronger binding affinity with the host group and pre-treated by FASP. Combined with liquid-mass spectrometry technology and label-free quantitative methods, the cell surface proteome is analyzed in situ. This method is of great significance for analyzing intercellular communication, the transport of ions and other molecules, and the transmission of signal cascades, understanding the pathways involved in diseases, immunity, drug resistance, and cell function differentiation, and finding new disease markers and new targets in drug development, thereby providing theoretical support for the occurrence and development of diseases, drug treatment, and inhibition of drug resistance.
本发明具有如下优点:The present invention has the following advantages:
(1)本发明通过主客体识别技术作为目标蛋白的富集方法,克服了生物素-亲和素富集体系可能污染富集蛋白、易丢失低丰度蛋白、富集蛋白难以回收等问题,使该发明成为低丰度细胞表面蛋白质组原位分析的有效方法。(1) The present invention uses host-guest recognition technology as a method for enriching target proteins, overcoming the problems of the biotin-avidin enrichment system that may contaminate the enriched proteins, easily lose low-abundance proteins, and make it difficult to recover the enriched proteins, making the present invention an effective method for in situ analysis of low-abundance cell surface proteomes.
(2)本发明将主客体对富集体系与多种反应位点的蛋白标记技术进行融合,解决了单一反应位点标记基团对蛋白的反应偏好性问题,并在主客体稳健的相互作用下,可以获得重现准确、覆盖度深的细胞表面蛋白质组原位鉴定。(2) The present invention integrates the host-guest pair enrichment system with the protein labeling technology of multiple reaction sites, which solves the problem of the response preference of the labeling group of a single reaction site to the protein. Under the robust interaction between the host and the guest, it can obtain reproducible and accurate in situ identification of the cell surface proteome with deep coverage.
(3)本发明将基于主客体相互作用的富集技术与无标定量蛋白质组方法相结合,解决了低丰度细胞表面蛋白质难以被准确定性定量分析的问题,能够用于低丰度细胞表面蛋白表达差异性的原位研究。(3) The present invention combines the enrichment technology based on host-guest interaction with the label-free quantitative proteomics method, which solves the problem that low-abundance cell surface proteins are difficult to accurately identify and quantify, and can be used for in situ research on the expression differences of low-abundance cell surface proteins.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1.Fe-Sulfo-NHS酯、Fe-N-NHS酯的合成流程示意图,其中,a为Fe-Sulfo-NHS酯的合成流程,b为Fe-N-NHS酯的合成流程。Figure 1. Schematic diagram of the synthesis process of Fe-Sulfo-NHS ester and Fe-N-NHS ester, wherein a is the synthesis process of Fe-Sulfo-NHS ester and b is the synthesis process of Fe-N-NHS ester.
图2.Fe-Sulfo-NHS酯、Fe-N-NHS酯的LTQ表征分子量,其中,a为Fe-Sulfo-NHS酯的LTQ表征分子量,b为Fe-N-NHS酯的LTQ表征分子量。Figure 2. LTQ molecular weights of Fe-Sulfo-NHS ester and Fe-N-NHS ester, where a is the LTQ molecular weight of Fe-Sulfo-NHS ester and b is the LTQ molecular weight of Fe-N-NHS ester.
图3.硅基-CB[7]的XPS表征结果。Fig. 3. XPS characterization results of Si-CB[7].
具体实施方式Detailed ways
实施例1Example 1
(1)制备硅基-CB[7]主体分子:在92mL无水乙醇中依次加入16mL去离子水、2.6mL氨水(28%)、3.44mL四乙氧基硅烷,室温反应16小时。反应结束后11000rpm离心弃上清得到粗产物二氧化硅,依次用去离子水和无水乙醇超声洗三遍,过夜烘干得到纯的二氧化硅。将制得的二氧化硅分散到40mL无水甲苯中,加入2mL 3-(2,3-环氧丙氧)丙基三甲氧基硅烷,120℃回流过夜。反应结束后11000rpm离心弃上清得到粗的环氧化二氧化硅,粗产物再依次用丙酮和无水乙醇各超声洗三遍,过夜烘干得到纯的环氧二氧化硅。制得的500mg环氧化二氧化硅与50mg CB[7]-OH在20mL乙腈中85℃回流反应5小时后加入100μL三乙胺继续反应12h,得到的粗产物用乙腈清洗3遍烘干得到纯的硅基-CB[7]主体材料。(1) Preparation of Silica-CB[7] Main Molecule: 16 mL of deionized water, 2.6 mL of ammonia (28%), and 3.44 mL of tetraethoxysilane were added to 92 mL of anhydrous ethanol in sequence, and the mixture was reacted at room temperature for 16 hours. After the reaction, the mixture was centrifuged at 11000 rpm and the supernatant was discarded to obtain crude silica, which was then ultrasonically washed three times with deionized water and anhydrous ethanol in sequence, and dried overnight to obtain pure silica. The obtained silica was dispersed in 40 mL of anhydrous toluene, 2 mL of 3-(2,3-epoxypropoxy)propyltrimethoxysilane was added, and the mixture was refluxed at 120°C overnight. After the reaction, the mixture was centrifuged at 11000 rpm and the supernatant was discarded to obtain crude epoxy silica, which was then ultrasonically washed three times with acetone and anhydrous ethanol in sequence, and dried overnight to obtain pure epoxy silica. 500 mg of the prepared epoxidized silica and 50 mg of CB[7]-OH were refluxed in 20 mL of acetonitrile at 85° C. for 5 hours, and then 100 μL of triethylamine was added to continue the reaction for 12 hours. The crude product was washed three times with acetonitrile and dried to obtain a pure silicon-CB[7] main material.
(2)制备Sulfo-NHS酯-二茂铁:将2mM二茂铁甲酸、2mM N-Boc、2.4mM HBTU、4mMDIEA用20mLDMF作溶剂放入50mL烧瓶中,超声使反应物充分分散,室温下充分反应12h制得油状物Fe-N-Boc(分子量为460.2),将反应得到的混合物经半制备液相提纯得到纯净Fe-N-Boc。半制备液相分离条件为:A相是0.1%三氟乙酸水溶液,B相是100%乙腈;梯度为:0-30min,30-60%B。将制得的Fe-N-Boc溶于20mL 5:2(v/v)的二氯甲烷:三氟乙酸中,室温反应2h后,旋蒸去除溶剂,再加入20mL二氯甲烷旋干,重复3次,得到纯净的Fe-N-NH2(分子量为360.2)。将0.2mM Fe-N-NH2与0.3mM戊二酸酐混合,加入三乙胺将溶液调制碱性(pH=9),在20mL二氯甲烷中50度回流12h,反应结束后旋干二氯甲烷,并用二氯甲烷清洗三遍得到较纯的Fe-N-COOH(分子量为474.1)。制得的0.1mM Fe-N-COOH与0.15mM EDC、0.15mM Sulfo-NHS混合,在20Ml DMF做溶剂的条件下反应12h,得到粗产物Fe-Sulfo-NHS酯。将粗产物经半制备液相提纯得到纯净的Fe-Sulfo-NHS酯。半制备液相条件为:A相是0.1%三氟乙酸水溶液,B相是100%乙腈;梯度为:0-30min,30-60%B。(2) Preparation of Sulfo-NHS ester-ferrocene: 2mM ferrocenecarboxylic acid, 2mM N-Boc, 2.4mM HBTU, 4mM DIEA were placed in a 50mL flask with 20mL DMF as solvent, and the reactants were fully dispersed by ultrasound. The oily substance Fe-N-Boc (molecular weight 460.2) was obtained by fully reacting at room temperature for 12 hours. The reaction mixture was purified by semi-preparative liquid phase to obtain pure Fe-N-Boc. The semi-preparative liquid phase separation conditions were: phase A was 0.1% trifluoroacetic acid aqueous solution, phase B was 100% acetonitrile; the gradient was: 0-30min, 30-60% B. The obtained Fe-N-Boc was dissolved in 20mL 5:2 (v/v) dichloromethane:trifluoroacetic acid, reacted at room temperature for 2 hours, and then the solvent was removed by rotary evaporation. 20mL dichloromethane was added and dried by rotary evaporation. This was repeated 3 times to obtain pure Fe-N-NH 2 (molecular weight 360.2). 0.2mM Fe-N-NH 2 was mixed with 0.3mM glutaric anhydride, triethylamine was added to adjust the solution to alkalinity (pH = 9), and refluxed in 20mL dichloromethane at 50 degrees for 12h. After the reaction, the dichloromethane was spin-dried and washed three times with dichloromethane to obtain relatively pure Fe-N-COOH (molecular weight 474.1). The prepared 0.1mM Fe-N-COOH was mixed with 0.15mM EDC and 0.15mM Sulfo-NHS, and reacted for 12h under the condition of 20mL DMF as solvent to obtain crude product Fe-Sulfo-NHS ester. The crude product was purified by semi-preparative liquid phase to obtain pure Fe-Sulfo-NHS ester. The semi-preparative liquid phase conditions are: phase A is 0.1% trifluoroacetic acid aqueous solution, phase B is 100% acetonitrile; gradient is: 0-30min, 30-60% B.
(3)应用Fe-Sulfo-NHS酯富集Hela细胞的质膜蛋白:(3) Enrichment of plasma membrane proteins of Hela cells using Fe-Sulfo-NHS ester:
将5×107的Hela细胞培养基吸净,用PBS清洗两次,加入10mL0.25mg/mL Fe-Sulfo-NHS酯/PBS溶液在4度摇床上标记5min。吸净标记试剂,加入10mL100mM甘氨酸/PBS溶液,放入4度摇床孵育10min猝灭反应,吸净猝灭试剂后加入用10mL TBS缓冲液洗1遍。加入含1%(v/v)蛋白酶抑制剂的RIPA(强)裂解液,按照每2×107细胞加入1mL比例加入,120W功率下超声2min,提取蛋白复合物。使用BCA试剂盒测得全蛋白浓度。将硅基-CB[7]用1mLRIPA活化三遍,加入蛋白悬液中,室温富集2h,离心去除上清。向材料中加入1mL的200mM二硫苏糖醇,56度水浴30min,进行蛋白质复合物样品变性还原。离心去除上清,并用1mL 50mM碳酸氢铵溶液清洗一次材料;随后加入1mL 200mM碘乙酰胺避光烷基化反应30min;离心去除上清,并用1mL 50mM碳酸氢铵溶液多次清洗;最后加入2μg胰蛋白酶(胰蛋白酶:蛋白质复合物质量比=1:25)酶解14h;16000g离心收集上清,即肽段样品。将得到的肽段样品冻干,用0.1%(v/v)甲酸复溶,利用液质联用进行数据采集。所有质谱采集的数据采用内置Andromeda搜索引擎的MaxQuant_1.6.5.0进行搜索,实验组与空白对照组进行无标定量搜库,利用Perseus_1.5.8.5软件对搜库结果进行数据处理,找出定量强度比值大于2、Uniquepeptide数目大于等于3的差异蛋白,在Uniprot网站和DAVID网站对蛋白的名称、细胞分布等信息进行注释。5×10 7 Hela cell culture medium was aspirated, washed twice with PBS, and labeled for 5 min on a shaker at 4 degrees with 10 mL of 0.25 mg/mL Fe-Sulfo-NHS ester/PBS solution. The labeling reagent was aspirated, and 10 mL of 100 mM glycine/PBS solution was added. The reaction was quenched in a shaker at 4 degrees for 10 min. After the quenching reagent was aspirated, 10 mL of TBS buffer was added to wash once. RIPA (strong) lysis buffer containing 1% (v/v) protease inhibitor was added at a ratio of 1 mL per 2×10 7 cells. The protein complex was extracted by ultrasonication at 120 W for 2 min. The total protein concentration was measured using a BCA kit. Silica-CB[7] was activated three times with 1 mL of RIPA, added to the protein suspension, enriched at room temperature for 2 h, and the supernatant was removed by centrifugation. 1 mL of 200 mM dithiothreitol was added to the material, and the protein complex sample was denatured and reduced by incubating in a water bath at 56 degrees for 30 min. The supernatant was removed by centrifugation, and the material was washed once with 1mL 50mM ammonium bicarbonate solution; then 1mL 200mM iodoacetamide was added for alkylation reaction in the dark for 30min; the supernatant was removed by centrifugation, and washed several times with 1mL 50mM ammonium bicarbonate solution; finally, 2μg trypsin (trypsin: protein complex mass ratio = 1:25) was added for enzymatic digestion for 14h; the supernatant was collected by centrifugation at 16000g, which was the peptide sample. The obtained peptide samples were lyophilized, re-dissolved with 0.1% (v/v) formic acid, and data were collected by liquid chromatography-mass spectrometry. All mass spectrometry data were searched using MaxQuant_1.6.5.0 with built-in Andromeda search engine, and the experimental group and the blank control group were searched without standard quantitative library. The search results were processed by Perseus_1.5.8.5 software to find differential proteins with quantitative intensity ratio greater than 2 and uniquepeptide number greater than or equal to 3, and the protein names, cell distribution and other information were annotated on the Uniprot website and DAVID website.
实施例2Example 2
(1)操作如实施例1中步骤(1)所示。(1) The operation is as shown in step (1) in Example 1.
(2)制备带NHS酯的二茂铁:将2mM二茂铁甲酸、2mM N-Boc、2.4mM HBTU、4mM DIEA用20mLDMF作溶剂放入50mL烧瓶中,超声使反应物充分分散,室温下充分反应12h制得油状物Fe-N-Boc(分子量为460.2),将反应得到的混合物经半制备液相提纯得到纯净Fe-N-Boc。半制备液相分离条件为:A相是0.1%三氟乙酸水溶液,B相是100%乙腈;梯度为:0-30min。将制得的Fe-N-Boc溶于20mL 5:2(v/v)的二氯甲烷:三氟乙酸中,室温反应2h后,旋蒸去除溶剂,再加入20mL二氯甲烷旋干,重复3次,得到纯净的Fe-N-NH2(分子量为360.2)。将0.2mMFe-N-NH2与0.3mM戊二酸酐混合,加入三乙胺将溶液调制碱性(pH=9),在20mL二氯甲烷中50度回流12h,反应结束后旋干二氯甲烷,并用二氯甲烷清洗三遍得到较纯的Fe-N-COOH(分子量为474.1)。制得的0.1mM Fe-N-COOH与0.15mM EDC、0.15mM NHS混合,在20mL DMF做溶剂的条件下反应12h,得到粗产物Fe-NHS酯。将粗产物经半制备液相提纯得到纯净的Fe-NHS酯。半制备液相条件为:A相是0.1%三氟乙酸水溶液,B相是100%乙腈;梯度为:0-30min,30-60%B。(2) Preparation of ferrocene with NHS ester: 2mM ferrocenecarboxylic acid, 2mM N-Boc, 2.4mM HBTU, 4mM DIEA were placed in a 50mL flask with 20mL DMF as solvent, and the reactants were fully dispersed by ultrasound. The oily substance Fe-N-Boc (molecular weight 460.2) was obtained by fully reacting at room temperature for 12 hours. The reaction mixture was purified by semi-preparative liquid phase to obtain pure Fe-N-Boc. The semi-preparative liquid phase separation conditions were: phase A was 0.1% trifluoroacetic acid aqueous solution, phase B was 100% acetonitrile; the gradient was: 0-30min. The obtained Fe-N-Boc was dissolved in 20mL 5:2 (v/v) dichloromethane:trifluoroacetic acid, reacted at room temperature for 2 hours, and then the solvent was removed by rotary evaporation. 20mL dichloromethane was added and dried by rotary evaporation. This was repeated 3 times to obtain pure Fe-N-NH 2 (molecular weight 360.2). 0.2mMFe-N-NH 2 was mixed with 0.3mM glutaric anhydride, triethylamine was added to adjust the solution to alkalinity (pH = 9), and refluxed in 20mL dichloromethane at 50 degrees for 12h. After the reaction, the dichloromethane was spin-dried and washed three times with dichloromethane to obtain relatively pure Fe-N-COOH (molecular weight 474.1). The prepared 0.1mM Fe-N-COOH was mixed with 0.15mM EDC and 0.15mM NHS, and reacted for 12h under the condition of 20mL DMF as solvent to obtain crude product Fe-NHS ester. The crude product was purified by semi-preparative liquid phase to obtain pure Fe-NHS ester. The semi-preparative liquid phase conditions are: phase A is 0.1% trifluoroacetic acid aqueous solution, phase B is 100% acetonitrile; gradient is: 0-30min, 30-60% B.
(3)应用Fe-N-NHS酯富集Hela细胞的质膜蛋白:(3) Enrichment of plasma membrane proteins of Hela cells using Fe-N-NHS ester:
将5×107的Hela细胞培养基吸净,用PBS清洗两次,加入10mL0.25mg/mL Fe-N-NHS酯/PBS溶液在4度摇床上标记5min。吸净标记试剂,加入10mL100mM甘氨酸/PBS溶液,放入4度摇床孵育10min猝灭反应,吸净猝灭试剂后加入用10mL TBS缓冲液洗1遍。加入含1%(v/v)蛋白酶抑制剂的RIPA(强)裂解液,按照每2×107细胞加入1mL比例加入,120W功率下超声2min,提取蛋白复合物。使用BCA试剂盒测得全蛋白浓度。将硅基-CB[7]用1mL RIPA活化三遍,加入蛋白悬液中,室温富集2h,离心去除上清。向材料中加入1mL的200mM二硫苏糖醇,56度水浴30min,进行蛋白质复合物样品变性还原。离心去除上清,并用1mL 50mM碳酸氢铵溶液清洗一次材料;随后加入1mL200mM碘乙酰胺避光烷基化反应30min;离心去除上清,并用1mL 50mM碳酸氢铵溶液多次清洗;最后加入2μg胰蛋白酶(胰蛋白酶:蛋白质复合物质量比=1:25)酶解14h;16000g离心收集上清,即肽段样品。将得到的肽段样品冻干,用0.1%(v/v)甲酸复溶,利用液质联用进行数据采集。所有质谱采集的数据采用内置Andromeda搜索引擎的MaxQuant_1.6.5.0进行搜索,实验组与空白对照组进行无标定量搜库,利用Perseus_1.5.8.5软件对搜库结果进行数据处理,找出定量强度比值大于2、Unique peptide数目大于等于3的差异蛋白,在Uniprot网站和DAVID网站对蛋白的名称、细胞分布等信息进行注释。5×10 7 Hela cell culture medium was aspirated, washed twice with PBS, and labeled for 5 min on a shaker at 4 degrees with 10 mL of 0.25 mg/mL Fe-N-NHS ester/PBS solution. The labeling reagent was aspirated, and 10 mL of 100 mM glycine/PBS solution was added. The reaction was quenched in a shaker at 4 degrees for 10 min. After the quenching reagent was aspirated, 10 mL of TBS buffer was added to wash once. RIPA (strong) lysis buffer containing 1% (v/v) protease inhibitor was added at a ratio of 1 mL per 2×10 7 cells. The protein complex was extracted by ultrasonication at 120 W for 2 min. The total protein concentration was measured using a BCA kit. Silica-CB[7] was activated three times with 1 mL of RIPA, added to the protein suspension, enriched at room temperature for 2 h, and the supernatant was removed by centrifugation. 1 mL of 200 mM dithiothreitol was added to the material, and the protein complex sample was denatured and reduced by water bath at 56 degrees for 30 min. The supernatant was removed by centrifugation, and the material was washed once with 1mL 50mM ammonium bicarbonate solution; then 1mL 200mM iodoacetamide was added for alkylation reaction in the dark for 30min; the supernatant was removed by centrifugation, and washed several times with 1mL 50mM ammonium bicarbonate solution; finally, 2μg trypsin (trypsin: protein complex mass ratio = 1:25) was added for enzymatic digestion for 14h; the supernatant was collected by centrifugation at 16000g, which was the peptide sample. The obtained peptide samples were lyophilized, re-dissolved with 0.1% (v/v) formic acid, and data were collected by liquid chromatography-mass spectrometry. All mass spectrometry data were searched using MaxQuant_1.6.5.0 with built-in Andromeda search engine, and the experimental group and the blank control group were searched without standard quantitative library. The library search results were processed by Perseus_1.5.8.5 software to find differential proteins with quantitative intensity ratio greater than 2 and unique peptide number greater than or equal to 3, and the protein name, cell distribution and other information were annotated on the Uniprot website and DAVID website.
实施例3Example 3
(1)操作如实施例1中步骤(1)(2)所示(1) The operation is as shown in steps (1) and (2) in Example 1.
(2)应用Fe-Sulfo-NHS酯富集分析血液病中常见细胞系K562、U937、HL-60、KG-1、Molm-13的细胞表面蛋白质组的差异蛋白:(2) Fe-Sulfo-NHS ester was used to enrich and analyze the differentially expressed proteins in the cell surface proteome of common hematological cell lines K562, U937, HL-60, KG-1, and Molm-13:
分别将5×107K562、U937、HL-60、KG-1、Molm-13的细胞培养基吸净,用PBS清洗两次,分别加入10mL0.25mg/mLFe-Sulfo-NHS酯/PBS溶液在4度摇床上标记5min。吸净标记试剂,加入10mL100mM甘氨酸/PBS溶液,放入4度摇床孵育10min猝灭反应,吸净猝灭试剂后加入用10mLTBS缓冲液洗1遍。加入含1%(v/v)蛋白酶抑制剂的RIPA(强)裂解液,按照每2×107细胞加入1mL比例加入,120W功率下超声2min,提取蛋白复合物。使用BCA试剂盒测得全蛋白浓度。将硅基-CB[7]用1mL RIPA活化三遍,加入蛋白悬液中,室温富集2h,离心去除上清。向材料中加入1mL的200mM二硫苏糖醇,56度水浴30min,进行蛋白质复合物样品变性还原。离心去除上清,并用1mL 50mM碳酸氢铵溶液清洗一次材料;随后加入1mL200mM碘乙酰胺避光烷基化反应30min;离心去除上清,并用1mL 50mM碳酸氢铵溶液多次清洗;最后加入2μg胰蛋白酶(胰蛋白酶:蛋白质复合物质量比=1:25)酶解14h;16000g离心收集上清,即肽段样品。将得到的肽段样品冻干,用0.1%(v/v)甲酸复溶,利用液质联用进行数据采集。所有质谱采集的数据采用内置Andromeda搜索引擎的MaxQuant_1.6.5.0进行搜索,实验组间进行无标定量搜库,实验组内蛋白的表达丰度用iBAQ值进行绝对定量,利用Perseus_1.5.8.5软件对搜库结果进行数据处理,找出相对定量强度比值大于2、Unique peptide数目大于等于3的差异蛋白,以及这些蛋白在各自组内的表达丰度,在Uniprot网站和DAVID网站对蛋白的名称、细胞分布等信息进行注释。寻找血液病中常见细胞系中共同高表达的细胞表面蛋白及各个细胞系之间表达有差异的细胞表面蛋白。The cell culture medium of 5×10 7 K562, U937, HL-60, KG-1, and Molm-13 cells was aspirated, washed twice with PBS, and labeled for 5 min on a shaker at 4 degrees with 10 mL of 0.25 mg/mL Fe-Sulfo-NHS ester/PBS solution. The labeling reagent was aspirated, and 10 mL of 100 mM glycine/PBS solution was added. The reaction was quenched in a shaker at 4 degrees for 10 min. After the quenching reagent was aspirated, 10 mL of TBS buffer was added to wash once. RIPA (strong) lysis buffer containing 1% (v/v) protease inhibitor was added at a ratio of 1 mL per 2×10 7 cells. The protein complex was extracted by ultrasonication at 120 W for 2 min. The total protein concentration was measured using a BCA kit. Silica-CB[7] was activated three times with 1 mL of RIPA, added to the protein suspension, enriched at room temperature for 2 h, and centrifuged to remove the supernatant. Add 1mL of 200mM dithiothreitol to the material, and place in a water bath at 56 degrees for 30min to denature and reduce the protein complex sample. Remove the supernatant by centrifugation, and wash the material once with 1mL of 50mM ammonium bicarbonate solution; then add 1mL of 200mM iodoacetamide for alkylation reaction in the dark for 30min; remove the supernatant by centrifugation, and wash it several times with 1mL of 50mM ammonium bicarbonate solution; finally, add 2μg of trypsin (trypsin: protein complex mass ratio = 1:25) for enzymatic digestion for 14h; collect the supernatant by centrifugation at 16000g, which is the peptide sample. The obtained peptide sample was lyophilized, re-dissolved with 0.1% (v/v) formic acid, and data was collected by liquid chromatography-mass spectrometry. All data collected by mass spectrometry were searched using MaxQuant_1.6.5.0 with built-in Andromeda search engine. Standard-free quantitative library search was performed between experimental groups. The expression abundance of proteins in the experimental groups was absolutely quantified using iBAQ values. The library search results were processed using Perseus_1.5.8.5 software to find differential proteins with relative quantitative intensity ratios greater than 2 and unique peptide numbers greater than or equal to 3, as well as the expression abundance of these proteins in their respective groups. The protein names, cell distribution and other information were annotated on the Uniprot website and DAVID website. Cell surface proteins that are commonly highly expressed in common cell lines in hematological diseases and cell surface proteins that are differentially expressed between cell lines were found.
实施例4Example 4
(1)操作如实施例1中步骤(1)(2)所示(1) The operation is as shown in steps (1) and (2) in Example 1.
(2)应用Fe-Sulfo-NHS酯富集K562-TRE3G-ETV6-MECOM细胞模型的细胞表面蛋白,并分析ETV6-MECOM基因引起的K562细胞表面蛋白质组的表达变化:(2) Fe-Sulfo-NHS ester was used to enrich the cell surface proteins of the K562-TRE3G-ETV6-MECOM cell model, and the expression changes of the K562 cell surface proteome caused by the ETV6-MECOM gene were analyzed:
将5×107的K562-TRE3G-ETV6-MECOM加DOX诱导(实验组)和未加DOX(对照组1)以及空载的加DOX诱导(对照组2)和未加DOX(对照组3)诱导的细胞培养基吸净,用PBS清洗两次,加入10mL0.25mg/mLFe-Sulfo-NHS酯/PBS溶液在4度摇床上标记5min。吸净标记试剂,加入10mL100mM甘氨酸/PBS溶液,放入4度摇床孵育10min猝灭反应,吸净猝灭试剂后加入用10mLTBS缓冲液洗1遍。加入含1%(v/v)蛋白酶抑制剂的RIPA(强)裂解液,按照每2×107细胞加入1mL比例加入,120W功率下超声2min,提取蛋白复合物。使用BCA试剂盒测得全蛋白浓度。将硅基-CB[7]用1mL RIPA活化三遍,加入蛋白悬液中,室温富集2h,离心去除上清。向材料中加入1mL的200mM二硫苏糖醇,56度水浴30min,进行蛋白质复合物样品变性还原。离心去除上清,并用1mL 50mM碳酸氢铵溶液清洗一次材料;随后加入1mL 200mM碘乙酰胺避光烷基化反应30min;离心去除上清,并用1mL 50mM碳酸氢铵溶液多次清洗;最后加入2μg胰蛋白酶(胰蛋白酶:蛋白质复合物质量比=1:25)酶解14h;16000g离心收集上清,即肽段样品。将得到的肽段样品冻干,用0.1%(v/v)甲酸复溶,利用液质联用进行数据采集。所有质谱采集的数据采用内置Andromeda搜索引擎的MaxQuant_1.6.5.0进行搜索,实验组与对照组进行无标定量搜库,利用Perseus_1.5.8.5软件对搜库结果进行数据处理,找出定量强度比值大于2、Unique peptide数目大于等于3的差异蛋白,在Uniprot网站和DAVID网站对蛋白的名称、细胞分布等信息进行注释。寻找因融合基因ETV6-MECOM的影响而产生的差异细胞表面蛋白。The culture medium of 5×10 7 K562-TRE3G-ETV6-MECOM cells induced with DOX (experimental group) and without DOX (control group 1) and empty cells induced with DOX (control group 2) and without DOX (control group 3) was aspirated, washed twice with PBS, and labeled for 5 minutes on a shaker at 4 degrees with 10 mL of 0.25 mg/mL Fe-Sulfo-NHS ester/PBS solution. The labeling reagent was aspirated, and 10 mL of 100 mM glycine/PBS solution was added, and the reaction was quenched on a shaker at 4 degrees for 10 minutes. After the quenching reagent was aspirated, 10 mL of TBS buffer was added to wash once. RIPA (strong) lysis buffer containing 1% (v/v) protease inhibitor was added at a ratio of 1 mL per 2×10 7 cells, and the protein complex was extracted by ultrasonication at 120 W for 2 minutes. The total protein concentration was measured using a BCA kit. Silica-CB[7] was activated three times with 1 mL RIPA, added to the protein suspension, enriched at room temperature for 2 h, and centrifuged to remove the supernatant. 1 mL of 200 mM dithiothreitol was added to the material, and the protein complex sample was denatured and reduced in a water bath at 56 degrees for 30 min. The supernatant was removed by centrifugation, and the material was washed once with 1 mL 50 mM ammonium bicarbonate solution; then 1 mL 200 mM iodoacetamide was added for alkylation reaction in the dark for 30 min; the supernatant was removed by centrifugation, and washed several times with 1 mL 50 mM ammonium bicarbonate solution; finally, 2 μg trypsin (trypsin: protein complex mass ratio = 1:25) was added for enzymatic digestion for 14 h; the supernatant was collected by centrifugation at 16000 g, which was the peptide sample. The obtained peptide sample was lyophilized, reconstituted with 0.1% (v/v) formic acid, and data was collected by liquid chromatography-mass spectrometry. All the data collected by mass spectrometry were searched using MaxQuant_1.6.5.0 with built-in Andromeda search engine. The experimental group and the control group were searched without label quantitative library. The search results were processed using Perseus_1.5.8.5 software to find differential proteins with quantitative intensity ratio greater than 2 and unique peptide number greater than or equal to 3. The protein name, cell distribution and other information were annotated on the Uniprot website and DAVID website. Differential cell surface proteins caused by the influence of the fusion gene ETV6-MECOM were found.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211602865.6A CN118169263A (en) | 2022-12-11 | 2022-12-11 | Cell surface proteome in-situ analysis method based on interaction of host and guest and without calibration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211602865.6A CN118169263A (en) | 2022-12-11 | 2022-12-11 | Cell surface proteome in-situ analysis method based on interaction of host and guest and without calibration |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118169263A true CN118169263A (en) | 2024-06-11 |
Family
ID=91357340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211602865.6A Pending CN118169263A (en) | 2022-12-11 | 2022-12-11 | Cell surface proteome in-situ analysis method based on interaction of host and guest and without calibration |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118169263A (en) |
-
2022
- 2022-12-11 CN CN202211602865.6A patent/CN118169263A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1456632B1 (en) | Methods for isolating and labeling sample molecules | |
Miyagi et al. | Proteolytic 18O‐labeling strategies for quantitative proteomics | |
Weerapana et al. | Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)—a general method for mapping sites of probe modification in proteomes | |
Tomohiro et al. | Cross‐linking chemistry and biology: development of multifunctional photoaffinity probes | |
AU2002303760A1 (en) | Methods for isolating and labeling sample molecules | |
US20060275842A1 (en) | Methods and kits useful for the simplification of complex peptide mixtures | |
WO2002099077A2 (en) | Methods and compositions related to tagging of membrane surface proteins | |
CN111777696B (en) | Method for specific reversible enrichment of nascent protein | |
AU2002256060A1 (en) | Methods and kits useful for the simplification of complex peptide mixtures | |
US20100167262A1 (en) | Method and reagent for the specific identification and quantification of one or more proteins in a sample using in particular inductively coupled plasma-mass spectrometry | |
EP1589341A2 (en) | Method of selective peptide isolation for the identification and quantitative analysis of proteins in complex mixtures | |
JP4679368B2 (en) | Detection / separation / identification method of expressed trace protein / peptide | |
CN118169263A (en) | Cell surface proteome in-situ analysis method based on interaction of host and guest and without calibration | |
Wang et al. | Mass spectrometry analysis of S-nitrosylation of proteins and its role in cancer, cardiovascular and neurodegenerative diseases | |
Guo et al. | A novel quantitative proteomics reagent based on soluble nanopolymers | |
Dong et al. | A brief introduction to chemical proteomics for target deconvolution. | |
JP2005017264A (en) | Method of detecting/separating/identifying micro amount of expression protein/peptide, and system therefor | |
Zhang | Proteomics and PTMomics to Unveil Metabolic Regulation | |
CN116559459A (en) | A method for identifying a ligand molecule binding target protein and binding site | |
KIM et al. | Review Recent methodological advances towards single-cell proteomics | |
WO2024167839A1 (en) | Multiplexed single cell proteomics | |
CN119470877A (en) | A biotinylated amino acid probe and its preparation method and application, and a method and application for identifying amino acid binding proteins | |
US20030003512A1 (en) | Directed enzymatic modification of analytes for affinity capture and analysis | |
CN117230534A (en) | Construction method and application of covalent molecular fragment library for designing and developing targeted covalent inhibitor | |
CN116337567A (en) | A Fast and Efficient Method for Chemical Proteomics Sample Preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |